Egil S. B.
- Country
- Norway
- Department
- Dpt of Oncology
Research Overview
- Prevention of Cardiac Dysfunction with LCZ696 in Early Breast Cancer Patients Receiving Anthracycline-Based Adjuvant Therapy: Randomized Placebo-Controlled Trial (PRADA‑II)
- Evaluation of Dose-Dense Cyclophosphamide in Patients with TP53 Mutated or Wild-Type Advanced Breast Cancer
- Evaluation of Palbociclib, Olaparib, and Pertuzumab in Personalized Treatment of High-Risk Breast Cancer: A Molecular Marker-Based Clinical Trial
Data & Insights
Has run more than one trial at 5 of 9 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in personalized treatment approaches for breast cancer, with particular emphasis on understanding molecular mechanisms of the disease. Their research focuses on high-risk mammary cancer and the role of TP53 mutations in breast cancer development and treatment response.
- Molecular Marker Analysis
- Treatment Response Assessment
- Personalized Therapy Development
Additional interests include investigating therapy resistance patterns and developing strategies for improved survival outcomes in breast cancer patients.
Precision Medicine
The investigator conducts research in targeted therapeutic approaches, focusing on identifying specific genetic markers that influence treatment effectiveness. Their work encompasses the study of cyclophosphamide efficacy in different genetic contexts of breast cancer.
- Genetic Profiling
- Treatment Response Prediction
- Drug Response Analysis
Their research extends to understanding objective response rates in various genetic subtypes of breast cancer.
Therapeutic Innovation
The investigator explores innovative treatment strategies for breast cancer, with a focus on dose-dense therapeutic regimens. Their research evaluates the effectiveness of different treatment approaches based on specific genetic markers.
- Treatment Protocol Development
- Clinical Response Evaluation
- Risk Assessment Strategies
Their work includes developing personalized treatment protocols based on molecular characteristics of breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.